Mild cognitive impairment in COVID-19 survivors: Measuring the brain fog
Arvind Vyas, Vasim Raja Panwar, Vaibhav Mathur, Parth Patel, Surabhi Mathur, Arvind Sharma, Raja Babu Panwar, Rajeev Gupta
Abstract
Background The coronavirus disease 2019 (COVID-19) pandemic has been impacting individuals throughout the world. Millions have been affected, and while many have recovered, a growing number of recovered COVID-19 patients are reportedly facing neurological symptoms, described as "slow thinking," "difficulty in focusing," "confusion," "lack of concentration," "forgetfulness," or "haziness in thought process." These experiences of mental fatigue, associated with and related to mild cognitive impairments, may be conceptually defined as "brain fog."
Topics & Concepts
Coronavirus disease 2019 (COVID-19)ConfusionPandemicCognitionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPsychologyCognitive impairmentCognitive declinePsychiatryDiseaseMedicineClinical psychologyDementiaInternal medicineInfectious disease (medical specialty)VirologyPsychoanalysisOutbreakLong-Term Effects of COVID-19Intensive Care Unit Cognitive DisordersCOVID-19 and Mental Health